New developments in adjuvants

Mechanisms of Ageing and Development

Volumn 93, Issue 1-3, 1997, Pages 171-177

  Donnelly, John J ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Adjuvants; Immune mechanisms; Vaccines

Indexed keywords

ADJUVANT; VACCINE;

CONFERENCE PAPER; DRUG DESIGN; IMMUNITY; PRIORITY JOURNAL; SYMPOSIUM;

ADJUVANTS, IMMUNOLOGIC; ALUMINUM; ANIMALS; CYTOKINES; DRUG DESIGN; EMULSIONS; HUMANS; LIPOPOLYSACCHARIDES; LIPOSOMES; POLYMERS; SAPONINS; VACCINATION; VACCINES, SYNTHETIC;

EID: 0030935238     PISSN: 00476374     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0047-6374(96)01810-6     Document Type: Conference Paper

References (17)

1. S. Shirodkar, R.L. Hutchinson, D.L. Perry, J.L. White and S.L. Hem, Aluminum compounds used as adjuvants in vaccines. Pharm Res, 7 (1990) 1282-1288.
2. P.J. Kniskern and W.L. Miller, Hepatitis B vaccines: Blueprints for vaccines of the future. In R.W. Ellis (ed.), Vaccines: New approaches to immunological problems, Butterworth-Heinemann, Boston, 1992, pp. 177-204.
3. T.R. Mosmann and R.L. Coffman, Th1 and Th2 cells: Different patterns of lymphokine secretion lead to different functional properties. Ann. Rev. Immunol., 7 (1989) 145-173.
4. 13C NMR spectroscopy. Carbohydr. Res., 280 (1996) 1-14.
5. J.T. Ulrich and K.R. Myers, Monophosphoryl lipid A as an adjuvant, past experiences and new directions. Pharm. Biotechnol., 6 (1995) 495-524.
6. A.C. Allison and N.E. Byars, Syntex adjuvant formulation. Res. Immunol., 143 (1992) 519-525.
7. G. Ott, G.L. Barchfeld and G. Van Nest, Enhancement of humoral response against human influenza vaccine with the simple submicron oil/water emulsion adjuvant MF59. Vaccine, 13 (1995) 1557-1562.
8. D.T. O'Hagan, J.P. McGee, J. Holmgren, A.M. Mowat, A.M. Donachie, K.H. Mills, W. Gaisford, D. Rahman and S.J. Challacombe, Biodegradable microparticles as controlled release antigen delivery systems. Vaccine, 11 (1993) 149-154.
9. J.L. Cleland, L. Barron, P.W. Berman, A. Daugherty, T. Gregory, A. Lim, J. Vennari, T. Wrin, and M.F. Powell, Development of a single-shot subunit vacine for HIV-1: Part 2. Defining optimal autoboost characteristics to maximize the humoral immune repsonse. J. Pharm. Sci., 60 (1996) 2289-2295.
10. R.L. Hunter and B. Bennett, The adjuvant activity of nonionic block polymer surfactants. II. Antibody formation and inflammation related to the structure of triblocks and octablock copolymers. J. Immunol., 133 (1984) 3167-3175.
11. A.K. Andrianov and M.P. LeGolvan, Characterization of poly[di(carboxylatophenoxy)phosphazene] by an aqueous gel permeation chromatography. J. Appl. Polymer Sci., 60 (1996) 2289-2295.
12. + cytotoxic T-cells by immunization with purified HIV-1 envelope protein in ISCOMs. Nature, 344 (1990) 873-875.
13. W.I. White, D.R. Cassatt, J. Madsen, S.J. Burke, R.M. Woods, N.M. Wassef, C.R. Alving and S. Koenig, Antibody and cytotoxic-T-lymphocyte responses to a single liposome-associated peptide antigen. Vaccine, 13 (1995) 1111-1122.
14. D.C. Powers, M.C. Manning, P.J. Hanscome and P.J.F. Pietrobon, Cytotoxic-T-lymphocyte responses to a liposome-adjuvanted influenza A virus vaccine in elderly adults. J. Infect. Dis., 172 (1995) 1103-1107.
15. L.C. Afonso, T.M. Scharton, L.Q. Vieira, M. Wysocka, G. Trinchieri and P. Scott, Administration of recombinant IL-12 in a vaccine against Leishmania major. Science, 263 (1994) 235-237.
16. M.H. Tao and R. Levy, Idiotype/granulocyte-macrophage colony-stimulating factor fusion protein as a vaccine for B-cell lymphoma. Nature, 362 (1993) 755-758.
17. F.R. Vogel and M.F. Powell, A compendium of vaccine adjuvants and excipients. In M.F. Powell and M.J. Newman (eds.), Vaccine Design: The Subunit and Adjuvant Aproach, Plenum Press, N.Y., 1995, pp. 141-228.